- Home
- VERX vs BBIO Comparison
VERX vs BBIO Comparison
Compare VERX & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERX
- BBIO
- Stock Information
- Founded
- VERX 1978
- BBIO 2015
- Country
- VERX United States
- BBIO United States
- Employees
- VERX N/A
- BBIO N/A
- Industry
- VERX Computer Software: Prepackaged Software
- BBIO Biotechnology: Pharmaceutical Preparations
- Sector
- VERX Technology
- BBIO Health Care
- Exchange
- VERX Nasdaq
- BBIO Nasdaq
- Market Cap
- VERX 6.1B
- BBIO 6.7B
- IPO Year
- VERX 2020
- BBIO 2019
- Fundamental
- Price
- VERX $39.57
- BBIO $34.25
- Analyst Decision
- VERX Buy
- BBIO Strong Buy
- Analyst Count
- VERX 11
- BBIO 12
- Target Price
- VERX $50.40
- BBIO $57.09
- AVG Volume (30 Days)
- VERX 994.6K
- BBIO 2.9M
- Earning Date
- VERX 05-07-2025
- BBIO 04-29-2025
- Dividend Yield
- VERX N/A
- BBIO N/A
- EPS Growth
- VERX N/A
- BBIO N/A
- EPS
- VERX N/A
- BBIO N/A
- Revenue
- VERX $687,057,000.00
- BBIO $127,415,000.00
- Revenue This Year
- VERX $16.73
- BBIO $89.10
- Revenue Next Year
- VERX $14.39
- BBIO $57.07
- P/E Ratio
- VERX N/A
- BBIO N/A
- Revenue Growth
- VERX 15.20
- BBIO N/A
- 52 Week Low
- VERX $30.26
- BBIO $21.62
- 52 Week High
- VERX $60.71
- BBIO $39.54
- Technical
- Relative Strength Index (RSI)
- VERX 55.92
- BBIO 50.58
- Support Level
- VERX $38.92
- BBIO $31.77
- Resistance Level
- VERX $40.13
- BBIO $33.93
- Average True Range (ATR)
- VERX 1.24
- BBIO 1.28
- MACD
- VERX 0.12
- BBIO -0.09
- Stochastic Oscillator
- VERX 84.31
- BBIO 57.14
About VERX Vertex Inc.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. Vertex provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting among others. The company derives revenue from software subscriptions.
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.